N/A
Completed N=22
Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa
Source: ClinicalTrials.gov NCT04600375 ↗Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Apr 2022
Primary outcomePrimary: Visits to High-cost Care Settings [ Time Frame: 1.5 Months ] — 0; 0 Participants
Summary
This study is being conducted to evaluate if a written action plan for hidradenitis suppurativa (HS) will help patients with hidradenitis suppurativa gain a better understanding of the condition and how to manage the condition on a daily basis compared to a routine verbal consultation.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visits to High-cost Care Settings [ Time Frame: 1.5 Months ] |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- This study will only enroll subjects between the ages of 18-years and 89-years of age.
- Diagnosis of HS by a board-certified dermatologist
- Able to read and comprehend study materials
- No prior exposure to written HS action plans
Exclusion Criteria
- Those who do not fit the inclusion criteria
Data sourced from ClinicalTrials.gov (NCT04600375). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.